Joel Dudley

Partner

2022 - Current

Investor, Board Member

2022

Investor, Board Member

2022

Investor, Board Member

2022

Scientific Advisor

2021

Associate Professor of Genetics and Genomic Sciences (w/ Tenure)

2016

Endowed Chair of Biomedical Data Science

2017 - 2019

Director of the Institute for Next Generation Healthcare

2016 - 2019

Director of Biomedical Informatics

2012 - 2019

Assistant Professor of Genetics and Genomic Sciences

2012 - 2016

Chief Scientific Advisor

2022 - 2023

Chief Scientific Officer

2020 - 2022

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions and deliver personalized patient care. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com

Senior Vice President, Research

2019 - 2020

Co-Founder and Scientific Advisor

2018 - 2021

Onegevity is a leading team of scientists and entrepreneurs with deep expertise in health, nutrition, molecular diagnostics, and artificial intelligence. Our mission is to empower individuals to find and maintain optimal health and wellness by democratizing access to actionable tools and information from leading-edge biomedical research. We develop products that customize scientific health and wellness innovations to fit individual characteristics and lifestyle so that you can stay unique and authentic in achieving your goals. Onegevity merged with Thorne in February of 2021 to create Thorne Health Tech (NASDAQ: THRN)

Executive Vice President for Precision Health

2018 - 2019

Scientific Advisor

2015 - 2019